Pharmacological impact on mucociliary clearance.
D000779:Anesthetics, Local / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D002923:Cilia / Q000187:drug effects; D002925:Ciliary Motility Disorders / Q000188:drug therapy*; D006801:Humans; D009093:Mucus / Q000378:metabolism; D010277:Parasympathomimetics / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D001261:Pulmonary Atelectasis / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000779:Anesthetics, Local; D010277:Parasympathomimetics; D013438:Sulfhydryl Compounds; D013566:Sympathomimetics; D010447:Peptide Hydrolases; D011241:Prednisone